LianBio
LIANY · OTCMCIK 1831283fmd_1674R0581490Z3KEAHE2R5CX82Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 15 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Net interest income | (5) | 0 | 4 |
| Research and development | 121 | 159 | 60 |
| Total operating expenses | 135 | 196 | 125 |
| Operating income | (135) | (196) | (125) |
| Other non-operating income (expense) | 0 | (0) | 10 |
| Income before taxes | (140) | (196) | (111) |
| Income tax expense | 0 | 1 | (0) |
| Net income from continuing operations | (140) | (196) | (110) |
| Net income | (140) | (196) | (110) |